GSK announced intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations
On May 28, 2020, GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant…
On May 28, 2020, GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant…
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
On May 28, 2020, Biogen and the Lemelson-MIT Program (LMIT) at the Massachusetts Institute of Technology announced the…
On May 28, 2020, Vaxxas announced that Merck had exercised its option to utilize Vaxxasメ proprietary High Density…
On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the FDA for…
On May 28, 2020, Roche announced it had initiated of a global phase III, randomised, double-blind, multicentre study…
On May 28, 2020, Atossa Therapeutics announced that it had begun the development of a second COVID-19 program…
On May 27, 2020, the NIH Nutrition Research Task Force (NRTF), armed with insights from the nutrition science…
On May 27, 2020, the National Institutes of Health (NIH) announced it had found that molecules released into…
On May 27, 2020, Gilead Sciences and Arcus Biosciences announced that the companies had entered into a 10-year…
On May 27, 2020, an analyses of the largest publicly available catalog of human genomic data revealed new…
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…
On May 27, 2020, Heat Biologics announced a collaboration with Waisman Biomanufacturing to establish a partnership for the…
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
On May 26, 2020, Sanofi announced that it had agreed to sell 11.8 million shares of Regeneron common…
On May 26, 2020, researchers at the Max Planck Institute for Evolutionary Anthropology in Germany and the Karolinska…
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
On May 26, 2020, the NIH announced a new study that provides an alternative treatment regimen that is…
On May 26, 2020, the FDA approved Amivas’ artesunate for injection to treat severe malaria in adult and…
On May 26, 2020, Royal Philips announced it had received 510(k) clearance from the FDA for its wearable…
On May 26, 2020, GenScript Biotech announced that it had obtained CE-IVD for its SARS-CoV-2 diagnostic products to…
On May 26, 2020, researchers at the University of Exeter Medical School and the UConn School of Medicine…
On May 26, 2020, Merck and and and Ridgeback Biotherapeutics announced a collaboration agreement to develop EIDD-2801, an…
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
On May 26, 2020, Cerecor and Myriad Genetics announced that levels of novel cytokine, LIGHT, were highly correlated…
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
On May 26, 2020, the FDA provided approval to Amivas for its artesunate for injection to treat severe…
On May 26, 2020, University of Nebraska Medical Center (UNMC) researchers were part of a large national study…
On May 26, 2020, Montefiore Health System and Albert Einstein College of Medicine began the next stage of…
On May 26, 2020, Todos Medical announced it had entered into a cross-distribution agreement with L1 Systems, a…